Prevalence of Anemia & Growth Assessment in Acute Gastroenteritis

Status Not yet recruiting

Clinical Trial Summary

1. Assessment of the growth parameters in infants admitted with acute gastroenteritis. 2. Determine the prevalence of anemia in infants admitted with acute gastroenteritis.

Clinical Trial Description

Gastroenteritis is inflammation of the stomach, small intestine, or large intestine, leading to a combination of abdominal pain, cramping, nausea, vomiting, and diarrhea. Acute gastroenteritis usually lasts fewer than 14 days. Worldwide, gastroenteritis affects 3 to 5 billion children each year. Up to 40% of children aged less than 5 years with diarrhea are hospitalized with rotavirus. Also, some microorganisms have been found predominantly in resource-constrained nations, including Shigella spp, Vibrio cholerae, and the protozoan infections. Malnutrition, immunosuppression, young age, and an increase in the preceding diarrhea burdens are risk factors for the development of persistent diarrhea. A substantial proportion of global malnutrition is due to impaired intestinal absorptive function resulting from multiple and repeated enteric infections. These include recurrent acute infections as well as persistent infections, even those without overt liquid diarrhea. Child growth is internationally recognized as the best global indicator of physical well-being in children because poor feeding practices-both in quantity and quality-and infections, or more often a combination of the two, are major factors that affect physical growth and mental development in children. The most important measurements needed for growth assessment are recumbent length or height, weight and head circumference. These fundamental anthropometric measures should be obtained and interpreted at each well child visit, and are typically sufficient for growth assessment. In this study, the prevalence of anemia and growth of infants admitted with acute gastroenteritis at Assiut University Children Hospital will be assessed. Anemia is a global public health problem, with important consequences for human health and the social and economic development of each nation. It results from single or multiple causes that act simultaneously, influencing children's health, their cognitive and physical development, and immunity, increasing the risk of infections and infant mortality. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06038305
Study type	Observational
Source	Assiut University
Contact	Gehad Ali
Phone	01011001797
Email	gehadali4397@gmail.com
Status	Not yet recruiting
Phase
Start date	June 2024
Completion date	February 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04682860` - Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide	Phase 4
Recruiting	`NCT03851835` - Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis	Phase 3
Completed	`NCT01577043` - Efficacy of Racecadotril in Acute Watery Diarrhea in Children	Phase 4
Completed	`NCT03234777` - Evaluating a Knowledge Translation Tool for Parents	N/A
Not yet recruiting	`NCT02619201` - Antiemetic Efficacy of Ondansetron Versus Metoclopramide	Phase 3
Completed	`NCT02280759` - Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children.	Phase 1
Completed	`NCT06090708` - Yogurt Probiotic Bacteria on Relieving Young Children Acute Gastroenteritis	N/A
Recruiting	`NCT05270291` - Infectious Etiology of Vomiting in Children With Presumed Acute Gastroenteritis
Completed	`NCT02025452` - Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis	Phase 4
Completed	`NCT02803827` - Optimizing the Management of Acute Diarrhoeal Disease	Phase 3
Completed	`NCT02644200` - Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis	Phase 3
Completed	`NCT02174874` - Ondansetron Oral Versus Orally Disintegrating Tablets (ODT)	N/A
Completed	`NCT03539913` - Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children	Phase 4
Recruiting	`NCT06137014` - Fortified Oral Rehydration Therapy for Pediatric Diarrhea	Phase 1/Phase 2
Completed	`NCT04463355` - Video Discharge Instructions for Pediatric Gastroenteritis in an Emergency Department	N/A
Completed	`NCT04555200` - Continuous Enteral Rehydration by Nasogastric Tube With ORS in Children With Acute Gastroenteritis
Completed	`NCT02169817` - Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children	Phase 4
Unknown status	`NCT02177799` - Surveillance Study of Acute Gastroenteritis in Hospitalized Children in Rural Area in Lebanon	N/A
Completed	`NCT01886755` - Efficacy of an Oral Rehydration Solution Containing the Probiotic Lactobacillus Reuteri Protectis and Zinc in Infants With Acute Gastroenteritis	N/A
Completed	`NCT01257672` - Symptomatic Treatment of Acute Gastroenteritis	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prevalence of Anemia and Growth Assessment in Acute Gastroenteritis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms